These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7869617)

  • 21. Simultaneous assessment of effects of coronary vasodilators on the coronary blood flow and the myocardial contractility by using the blood-perfused canine papillary muscle.
    Himori N; Ono H; Taira N
    Jpn J Pharmacol; 1976 Aug; 26(4):427-35. PubMed ID: 1003699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronotropic, inotropic, dromotropic and coronary vasodilator effects of bisaramil, a new class I antiarrhythmic drug, assessed using canine isolated, blood-perfused heart preparations.
    Haruno A; Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 1999 Jul; 80(3):267-70. PubMed ID: 10461773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrocardiographic interactions between pinacidil, a potassium channel opener and class I antiarrhythmic agents in guinea-pig isolated perfused heart.
    Yang Q; Padrini R; Bova S; Piovan D; Magnolfi G
    Br J Pharmacol; 1995 Apr; 114(8):1745-9. PubMed ID: 7599944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of antiarrhythmic drugs on canine ventricular arrhythmia models: which electrophysiological characteristics of drugs are related to their effectiveness?
    Hashimoto K; Haruno A; Matsuzaki T; Sugiyama A; Akiyama K
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():805-17. PubMed ID: 1657110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular effects of optical isomers of cibenzoline, assessed in the canine isolated, blood-perfused papillary muscle and sinoatrial node preparations.
    Takehana S; Sugiyama A; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):660-5. PubMed ID: 10547081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of sinoatrial conduction time with therapeutic doses of antiarrhythmic agents in isolated cross-perfused canine atria.
    Shimotori M; Kobayashi M; Chiba S
    Jpn Heart J; 1985 Jan; 26(1):113-22. PubMed ID: 4009954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
    Pourrias B; Santamaria R
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new class-III antiarrhythmic preparation among the dicyclohexylamides of aminocarboxylic acids].
    Kaverina NV; Lyskovtsev VV; Sokolov SF; Poppe H; Marx D; Kishchuk EP; Turilova AI; Likhosherstov AM; Tsorin IB; Chichkanov GG
    Vestn Ross Akad Med Nauk; 1998; (11):42-6. PubMed ID: 9889705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined application of class I antiarrhythmic drugs causes "additive", "reductive", or "synergistic" sodium channel block in cardiac muscles.
    Kawamura T; Kodama I; Toyama J; Hayashi H; Saito H; Yamada K
    Cardiovasc Res; 1990 Nov; 24(11):925-31. PubMed ID: 2176934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated, perfused hearts.
    Takeo S; Tanonaka K; Hayashi M; Yamamoto K; Liu JX; Kamiyama T; Yamaguchi N; Miura A; Natsukawa T
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1403-9. PubMed ID: 7791114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on mechanisms of diltiazem-induced protection of the ischemic myocardium: selective myocardial depressant action of diltiazem on an ischemic isolated blood-perfused canine papillary muscle preparation.
    Ngai JH; Yabuuchi Y; Schwartz A; Millard RW
    J Pharmacol Exp Ther; 1983 May; 225(2):462-9. PubMed ID: 6842404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency-dependent and independent effects of tetrodotoxin on Vmax in cardiac fibers.
    Varró A; Nakaya Y; Elharrar V; Surawicz B
    Acta Physiol Hung; 1989; 73(1):47-52. PubMed ID: 2711842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
    Gotanda K; Yanagisawa T; Satoh K; Taira N
    Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
    Orito K; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent.
    Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M
    Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.